Cummins Inc
Change company Symbol lookup
Select an option...
CMI Cummins Inc
INVH Invitation Homes Inc
OII Oceaneering International Inc
SINO Sino-Global Shipping America Ltd
MLM Martin Marietta Materials Inc
KO Coca-Cola Co
VICI VICI Properties Inc
PLT Plantronics Inc
THG Hanover Insurance Group Inc
USB U.S. Bancorp

Industrials : Machinery | Large Cap Value
Company profile

Cummins Inc. designs, manufactures, distributes and services diesel and natural gas engines and engine-related component products. The Company's segments include Engine, Distribution, Components and Power Systems. The Engine segment manufactures and markets a range of diesel and natural gas powered engines under the Cummins brand name, as well as certain customer brand names, for the heavy and medium-duty truck, bus, recreational vehicle (RV), light-duty automotive and agricultural markets. The Distribution segment consists of the product lines, which service and/or distribute a range of products and services, including parts, engines, power generation and service. The Components segment supplies products, including aftertreatment systems, turbochargers, filtration products and fuel systems for commercial diesel applications. The Power Systems segment consists of businesses, including Power generation, Industrial and Generator technologies.


Last Trade
0.00 (0.00%)
B/A Size

Market Hours

Closing Price
Day's Change
2.45 (1.13%)
B/A Size
Day's High
Day's Low

10-day average volume:

AHF Applauds Congressional Demand that Drug Companies Follow Laws on 340B Drug Program

2:22 pm ET September 15, 2020 (BusinessWire) Print

AIDS Healthcare Foundation (AHF) expressed its appreciation to the 243 members of the U.S. House of Representatives who sent a letter to U.S. Health and Humans Services Secretary Alex Azar demanding that the agency stop drug companies from violating their legal obligations under the 340B Drug Discount Program statute.

"Drug companies are not above the law," said Tom Myers, general counsel and chief of public affairs for AHF. AstraZeneca, Eli Lilly, Merck, Novartis and Sanofi recently announced that they would limit their statutory responsibility to provide drug discounts to non-profit safety net providers," Myers added, "The 340B statute certainly doesn't allow drug companies to set conditions for safety net providers to access 340B discounts. Their idea that manufacturers can unilaterally regulate the program themselves is ridiculous and has been rejected by 243 members of Congress."

"This rare bipartisan message to the Health and Human Services Department says to drug companies: 'Back off!'" said John Hassell, national director of advocacy for AHF. "While members of Congress are often divided on policy, this letter sends a strong message that Congress supports the 340B program and will not tolerate drug manufacturers making up the rules." He added, "The letter demands that Secretary Azar take immediate action to 'ensure covered entities continue to receive crucial 340B drug discounts.'"

"The funds safety net providers realize through the 340B program, which they use to increase vitally-needed medical services, don't cost the taxpayers a single cent. 340B discounts are a sliver of the overall Medicare and Medicaid market from which drug companies reap record profits every quarter," said Tracy Jones, senior manager national director of mobilization campaigns for AHF. "340B savings keep our doors open, keep people living with HIV in routine care, and help strengthen our healthcare safety net already under tremendous stress."

"This troubling move by drug companies against non-profit safety net providers is a sign that 'big pharma' hasn't given up trying to strangle the 340B program. AHF is delighted to see the majority of the U.S. House of Representatives defend 340B," said Hassell.

About AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.4 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website:, find us on Facebook: and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

View source version on

SOURCE: AIDS Healthcare Foundation">

John Hassell, National Director of Advocacy, AHF +1.202.774.4854 [cell] 
Ged Kenslea, Senior Director, Communications, AHF +1.323.791.5526 [cell] +.323.308.1833 [work]
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.